Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Appendix 4C

20 April 2017 by Audrey Thomson

Appendix 4C

Categories 2017, ASX Announcements
Post navigation
Quarterly Report 31 March 2017
Independent Research Highlights the Need for Drugs Targeting HIV-1 in Macrophages
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 24 February 2021        Legal Notices and Privacy